Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Changes in Serum Lipoproteins in Psoriasis

Changes in Serum Lipoproteins in Psoriasis Abstract If psoriasis is a disease of systemic lipid metabolism, some deviation from the normal should be found in the serum lipoprotein levels of psoriatic patients. It has been shown that the lipid constituents in the serum, including phospholipids, neutral fats, triglycerides, cholesterol, and cholesterol esters, are carried primarily as lipid-protein complexes called lipoproteins.1,2 The best method at present for studying these relatively unstable compounds is by the technique of ultracentrifugation. This study was undertaken to determine what changes, if any, occur in serum lipoprotein fractions of patients with psoriasis when treated by various means. In recent publications it has been demonstrated that patients with psoriasis show no consistent variation from the normal with regard to serum lipoproteins. No significant abnormalities were found by Lea et al.3 in the serum lipoproteins of patients with psoriasis, and these findings were confirmed in our own preliminary report.4 The possibility remains, References 1. Gofman, J. W.; Lindgren, F. T., and Elliott, H. A.: Ultracentrifugal Studies of Lipoproteins of Human Serum , J. Biol. Chem. 179:973-979, 1949. 2. De Lalla, O. F., and Gofman, J. W.: Ultracentrifugal Analysis of Serum Lipoproteins , in Glick, D.: Methods of Biochemical Analysis , Vol. 1, New York, Interstate Publishers, Inc., 1954. 3. Lea, W. A., Jr.; Cornish, H. H., and Block, W. D.: Studies on Serum Lipids, Proteins, and Lipoproteins in Psoriasis , J. Invest. Dermat. 30: 181-185 ( (April) ) 1958. 4. Shapiro, E. M.; Knox, J. M., and Grundy, S.: Serum Lipoproteins in Psoriasis , J. Invest. Dermat. 31:215-217 ( (Oct.) ) 1958.Crossref 5. Pearson, S.; Stern, S., and McGavack, T. H.: A Rapid Procedure for the Determination of Serum Cholesterol , J. Clin. Endocrinol. 12:1245-1246, 1952.Crossref 6. Gross, P., and Kesten, B. M.: The Treatment of Psoriasis as a Disturbance of Lipid Metabolism , New York J. Med. 50:2683-2686 ( (Nov. 15) ) 1950. 7. Combes, F.: Management of Psoriasis as a Metabolic Lipid Disturbance , New York J. Med. 54:1945-1949 ( (July 1) ) 1954. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png A.M.A. Archives of Dermatology American Medical Association

Changes in Serum Lipoproteins in Psoriasis

Loading next page...
 
/lp/american-medical-association/changes-in-serum-lipoproteins-in-psoriasis-QURhDZMc0u
Publisher
American Medical Association
Copyright
Copyright © 1960 American Medical Association. All Rights Reserved.
ISSN
0096-5359
DOI
10.1001/archderm.1960.03730060056010
Publisher site
See Article on Publisher Site

Abstract

Abstract If psoriasis is a disease of systemic lipid metabolism, some deviation from the normal should be found in the serum lipoprotein levels of psoriatic patients. It has been shown that the lipid constituents in the serum, including phospholipids, neutral fats, triglycerides, cholesterol, and cholesterol esters, are carried primarily as lipid-protein complexes called lipoproteins.1,2 The best method at present for studying these relatively unstable compounds is by the technique of ultracentrifugation. This study was undertaken to determine what changes, if any, occur in serum lipoprotein fractions of patients with psoriasis when treated by various means. In recent publications it has been demonstrated that patients with psoriasis show no consistent variation from the normal with regard to serum lipoproteins. No significant abnormalities were found by Lea et al.3 in the serum lipoproteins of patients with psoriasis, and these findings were confirmed in our own preliminary report.4 The possibility remains, References 1. Gofman, J. W.; Lindgren, F. T., and Elliott, H. A.: Ultracentrifugal Studies of Lipoproteins of Human Serum , J. Biol. Chem. 179:973-979, 1949. 2. De Lalla, O. F., and Gofman, J. W.: Ultracentrifugal Analysis of Serum Lipoproteins , in Glick, D.: Methods of Biochemical Analysis , Vol. 1, New York, Interstate Publishers, Inc., 1954. 3. Lea, W. A., Jr.; Cornish, H. H., and Block, W. D.: Studies on Serum Lipids, Proteins, and Lipoproteins in Psoriasis , J. Invest. Dermat. 30: 181-185 ( (April) ) 1958. 4. Shapiro, E. M.; Knox, J. M., and Grundy, S.: Serum Lipoproteins in Psoriasis , J. Invest. Dermat. 31:215-217 ( (Oct.) ) 1958.Crossref 5. Pearson, S.; Stern, S., and McGavack, T. H.: A Rapid Procedure for the Determination of Serum Cholesterol , J. Clin. Endocrinol. 12:1245-1246, 1952.Crossref 6. Gross, P., and Kesten, B. M.: The Treatment of Psoriasis as a Disturbance of Lipid Metabolism , New York J. Med. 50:2683-2686 ( (Nov. 15) ) 1950. 7. Combes, F.: Management of Psoriasis as a Metabolic Lipid Disturbance , New York J. Med. 54:1945-1949 ( (July 1) ) 1954.

Journal

A.M.A. Archives of DermatologyAmerican Medical Association

Published: Jun 1, 1960

References